0
0
1/16/26 at 4:04pm
Organization
Benzinga
Author
Surbhi Jain
33 words
0
Comments
Hedge funds have been anticipating a surge in ImmunityBio's revenue, which has grown by 700% year-over-year.
You are the first to view
https://www.benzinga.com/markets/hedge-funds/26/01/49969034/immunitybios-700-revenue-boom-becomes-citadels-latest-i%e2%80%91told%e2%80%91you%e2%80%91so
Create an account
or login to join the discussion